Allspring Global Investments Holdings, LLC Kura Oncology, Inc. Transaction History

Allspring Global Investments Holdings, LLC

$59.3 Billion
Q4 2024

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 27, 2023	BUY	$8.44 - $11.86 $2,954 - $4,151	350 New	350 $3,000
Q2 2023 Jul 18, 2023	SELL	$9.62 - $13.99 $23,751 - $34,541	-2,469 Reduced 60.38%	1,620 $17,000
Q1 2023 Apr 13, 2023	BUY	$10.71 - $14.6 $34,786 - $47,420	3,248 Added 386.21%	4,089 $50,000
Q4 2022 Jan 23, 2023	SELL	$11.23 - $16.9 $213 - $321	-19 Reduced 2.21%	841 $0
Q3 2022 Oct 26, 2022	BUY	$12.01 - $19.45 $10,328 - $16,727	860 New	860 $11,000

Others Institutions Holding KURA

# of Institutions

196

Shares Held

79.6M

Call Options Held

98.7K

Put Options Held

70.1K

Black Rock Inc. New York, NY

6.97M
Shares

$57.7 Million
0.0% of portfolio
Armistice Capital, LLC New York, NY

5.8M
Shares

$48 Million
0.71% of portfolio
Suvretta Capital Management, LLC New York, NY

5.08M
Shares

$42 Million
1.84% of portfolio
Vanguard Group Inc Valley Forge, PA

4.82M
Shares

$39.9 Million
0.0% of portfolio
Ra Capital Management, L.P. Boston, MA

4.45M
Shares

$36.9 Million
0.63% of portfolio

View Full List

About Kura Oncology, Inc.

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $554M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

More about KURA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Account